The oncolytic activity of Clostridium novyi nontoxic spores in breast cancer

Fatemeh Abedi Jafari ¹ , Asghar Abdoli ² * , Reza Pilehchian ³, Neda Soleimani ¹, Seyed Masoud Hosseini ¹

Cited by CrossRef: 2

1- Behboodi R, Saadati Partan A, Meidaninikjeh S, Morvarid Y, Hosseininia H, Sayhinouri M, Shirinsokhan A, Javadi S, Ebrahimi Sadrabadi A, Jalili A. Clostridium Bacteria: The Team of Microscopic Oncologists. Iranian Journal of Blood and Cancer. 2023;15(4):178 [Crossref]

2- Ebadi Sharafabad B, Abdoli A, Panahi M, Abdolmohammadi Khiav L, Jamur P, Abedi Jafari F, Dilmaghani A. Anti-tumor Effects of Cisplatin Synergist in Combined Treatment with Clostridium novyi-NT Spores Against Hypoxic Microenvironments in a Mouse Model of Cervical Cancer Caused by TC-1 Cell Line. Adv Pharm Bull. 2023;13(4):817 [Crossref]

3- Zhu D, Pan W, Li H, Hua J, Zhang C, Zhao K. Innovative Applications of Bacteria and Their Derivatives in Targeted Tumor Therapy. ACS Nano. 2025;19(5):5077 [Crossref]

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons